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ABSTRACT
PREPARATION AND CHARACTERIZATION OF A SITE-DIRECTED
MUTANT OF ESCHERICHIA COZ/Z-THREONINE DEHYDROGENASE
By
Qian Zhou
Threonine dehydrogenase from E.coli is a member of the medium-chain, Zn """-containing
alcohol dehydrogenase family. A site-directed mutant of theronine dehydrogenase was prepared
at position 88 by replacing the native glutamate with cysteine using polymerase chain reaction.
The mutated enzyme, designated TDH E88C, was expressed and purified to homogeneity in a
three-step chromatographic procedure. The activity of the mutant after each step of purification
was determined by a specific assay. Both the total activity and the specific activity of TDH E99C
were significantly decreased compared to the wild-type TDH. The mutant enzyme was not
sufficiently stable to obtain reliable Vmax or Km values, preventing a quantitative comparison to
the wild type enzyme. Therefore, a definitive conclusion on the role of the Glu-88 remains
unresolved, pending further studies in the future.
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Z-threonine dehydrogenase catalyzes the NAD+-dependent oxidation of threonine to
aminoacetone and based on primary sequence homology, it is a member of the zinc-containing
medium-chain alcohol dehydrogenase family.
*t* Alcohol dehydrogenase families
Alcohol dehydrogenases and related enzymes constitute a complex system of different
enzymes, classes, isozymes, and allelic variants derived from gene duplications at minimally five



















Figure 1. Schematic representation of alcohol dehydrogenase relationships with emphasis on medium
chain alcohol dehydrogenase
family.1
Five different levels of relationship are distinguished, level 1
represents family multiplicity, level 2 represents enzyme multiplicity, level 3 represents class multiplicity,
level 4 represents isoenzyme multiplicity. Level 5 represents allelic variants. ADH, alcohol
dehydrogenase, SDH, sorbitol dehydrogenase; Cr, zeta-crystallin; XDH, xylitol dehydrogenase; TDH,
threonine dehydrogenase. I-V, ADH classes; a, P, y, ADH class I subunits; k, ADH class II subunit; x,
ADH class IH subunit; a (or u,), ADH class IV subunit.
? First level: family multiplicity
The most distant relationships are the separate protein families with different primary
amino acid sequences (especially highly conserved residues or conservatively replaced residues),
catalytic mechanisms (such as metal ion requirement) and varied subunit sizes. The
zinc-
containing medium-chain alcohol dehydrogenase family is the one that has approximately 370
amino acid per subunit and typically requires zinc at the active site while the short-chain
dehydrogenase family usually contain 250-300 amino acids per subunit functioning without
metal cof
actors.2
The zinc-containing medium-chain alcohol dehydrogenase family has been studied most
extensively such as liver alcohol dehydrogenases, E.coli threonine dehydrogenase, liver sorbital
dehydrogenase. The short-chain dehydrogenase family includes about 50 different enzymes
known as mammalian sugar, steroid, prostaglandin (non-alcohol) dehydrogenases and insect
alcohol dehydrogenases. Examples are Drosophila alcohol dehydrogenase, ribitol dehydrogenase
from Klebsiella
aerogenes3
and glucose dehydrogenase from Bacillus
megaterium.4
No short-
chain ethanol dehydrogenase has been identified in human tissues yet. Apart from the short-chain
family and the medium-chain family, "other
families"
of alcohol dehydrogenase also exist and
include a long-chain family and a family of iron-activated enzymes. They are known from
prokaryotic and fungal sources such as an alcohol dehydrogenase from Zymomonas
mobilis5
and
ADH4 from the yeast S.
cerevisiae,6
but have yet not been studied in great detail.
The
NAD+
binding units are the segments of maximum similarity among many
enzymes,7
The short-chain dehydrogenases have the characteristic P-stranded NAD+-binding
fold8
in the N-terminal region, rather than in the C-terminal region typical of the medium-chain
family.
The enzymes in the medium-chain alcohol dehydrogenase family typically contain a
catalytically active zinc atom at the active site, but it is not an absolute characteristic of the
family. ^-Crystallin, an enzyme initially discovered as a lens
crystailin9
and later found with
NADPH: quinone oxidoreductase enzymatic
activity,10
exhibits a typical overall protein
homology but lacks the zinc ligands and the zinc
atom.11
Some members of this family of
alcohol dehydrogenases also has a second zinc atom per subunit
("structural"
zinc); although it is
not found in some family members, including sorbitol
dehydrogenase.12
? Second level: enzyme multiplicity
The second level of gene duplications represents the different enzymes based on substrate
specificity. They are distantly related and with no substrates in common, hence constituting truly
different enzymes, however enzymes at this level are related conformationally. Thus, model
building is possible and relationships regarding zinc-binding properties, subunit interactions and
1 T
active site structures can be deduced from comparisons.
? Level three: class multiplicity
Level three gives rise to different classes of enzymes in ADH. They do not cross-
hybridize which means the subunit of each different class can't combine freely to form
heterodimers, only class-specific homodimers can be formed. They are different in expression,
regulation or substrate specificity. Nevertheless, the different classes have some activity toward a
common substrate, efhanol.
At least five classes of alcohol dehydrogenase are found in tissues of humans and many
other vertebrates. Class I represents the classical liver enzyme, exhibiting considerable activity
toward efhanol, sensitivity to pyrazole irihibition, and frequent existence of isozymes. Class in is
a dual enzyme that has alcohol dehydrogenase activity and also is identical to the glutathione-
dependent formaldehyde
dehydrogenase.14
This enzyme is the form of most distant origin and
involved in basic cellular defense
mechanisms.15
Class IV is present in
stomach1
and has the
highest ethanol activity of all classes thus far
characterized.17
Class II and classes V have not
been analyzed thoroughly.
? Fourth level: isozyme multiplicity
The fourth level of gene duplication during mammalian evolution constitutes isozyme
formation. This level was discovered quite recently and has been characterized only for the
mammalian class I enzymes. In humans, three isozyme subunits, a, P and y, associate freely into
all possible dimeric combinations.
? Fifth level: allelic variants
In addition to these four levels, further multiplicity derives from allelic variability. At
least three alleles (Pi, P2, P3) have been characterized for the human class I p form and two (yi,
y-i) for the class I y
form.1
These isozymes are responsible for the main efhanol metabolism in
liver but exhibit differences in substrate specificity and catalytic efficiency. Steroid
dehydrogenase activity has only been shown for isozymes containing the y
subunit20
and they are




in enzyme structure and activity
Zinc is an important component to many enzymes. It has been found to be an integral
component of nearly 300 enzymes in different species. About a decade ago, the role of zinc in
gene expression began to attract interest. Zinc also stabilizes the structure of proteins and
nucleic acids, plays an important role in catalysis, preserves the integrity of subcellular
organelles, participates in transport processes and viral immune
phenomena.23
Its nutritional
essentiality has focused attention on the pathology and clinical consequences of both its
deficiency and
toxicity.24
Members of the medium chain zinc-containing alcohol dehydrogenase family contain
catalytic zinc atoms and, in some cases, structural zinc atoms. The active site zinc in ADH is
bound to three amino acid side chains: The first two ligands, cysteine and histidine, are
conserved in the ADH active site. The third ligand may be either cys, glu, or asp (Table I). The
forth ligand is a water molecules if inhibitors or substrate are not present.
The crystal structure of horse liver alcohol dehydrogenase (EC 1.1.1.1) is already known
and hence can serve as a model for catalytic and structural zinc sites. It is a dimeric molecule,
each subunit is made up of two domains, the coenzyme binding domain, which contains residues
for NAD binding, and the catalytic domain which contains most residues responsible for
substrate (efhanol) binding including an active site zinc ion (Fig. 2).
The structural zinc atoms are coordinated to four cysteine residues, which are highly
conserved among many enzymes. The structural zinc is close to the surface of the molecule and
forms tetrametric geometry with its cysteine ligands (Fig. 2 and Fig. 3). This structural zinc atom
might primarily affect local structure and
conformation.25
The ligands of the active-site zinc atom of horse liver alcohol dehydrogenase were
identified by x-ray crystallography. The catalytic zinc is located in a deep cleft between the
catalytic and coenzyme-binding domains. It is bound to residues Cys-46, His-67 and Cys-174
(Fig. 4 and Fig. 5). The involvement of both zinc and NADH in the catalytic process requires
suitable alignment of amino acid residues that can provide for both metal chelation and
coenzyme binding sites. In LADH this has been accomplished by the use of residues Cys-46 and
Arg-47 as zinc and NADH-binding ligands, respectively, with two cysteines and one histidine as
ligands to the active-site zinc. When NAD binds to the enzyme, the catalytic domains rotate
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towards the coenzyme binding domain, tightening the interactions with NAD and excluding
water from the central part of the active
site.2
The reaction catalyzed by LADH is sequentially
ordered:27NAD+
binds to the enzyme
first. Then the alcohol substrate displaces the fourth ligand of the catalytic Zn2+-a water
molecule. The hydroxy! group of the substrate ligates to this metal ion. Binding to the positively
charged
NAD+
and the zinc decreases the pKa of the alcohol hydroxyl group, triggering a rapid
deprotonation of the alcohol. Hydride transfer from the substrate to
NAD"1"
results in an aldehyde
product. This is followed by dissociation of the aldehyde product and a subsequent association of




Horse E T G I C R S D I A G H E A A L I G C G F S
Human a V G I C G T D I L G H E A A L I G C G F S
Human P V G I C R T D I L G H E A A L I G C G F S
Human y A G I C R S D I L G H E A A L I G C G F S
Human 7t T S L C H T D I V G H E A A L I G C G F S
Human % T A V c R S D I L G H E G A L I G C G I S
E coli T A I c G T D V V G H E Y V I F
-
D P F G
Yeast 1 S G V c H T D V G G H E G A P V L C A G I
Yeast 2 S G V c H T D V G G H E G A P I L C A G I
Yeast 3 S G V c H T D V G G H E G A P I L c A G V
Yeast 4 T G V c H T D I G G H E G A P I M c A G I
Sheep SDH V G I c G S D V L G H E A S L I E P L s
Table I. Active-site zinc ligands for alcohol dehydrogenases. E.coli refer to E.coli TDH. Yeasts 1 and 2
are respectively Saccharomyces cerevisiae cytosolic isozymes 1 and 2, yeast 3 is a S. cerevisiae








Figure 2 Representation for one subunit of horse LADH (protein data bank file 1BTO) showing the
structural
Zn2+










Figure 3. A close up view of structural zinc








Figure 4. Representation of one subunit of 3-D structural of horse liver alcohlol dehydrogenase
complexed with co-enzyme
NAD+
and substrate SSB (Protein data back file 1BTO) showing the





Figure 5. A close-up look of active site
Zn2+
and its ligands.
Z-threonine is the 2(S), 3(R) stereoisomer of 2-amino-3-hydroxybutyrate. It was isolated
from hydrolysates of the blood protein, fibrin, and determined byW. C. Rose and his colleagues
to be the last essential amino acid required for the normal growth and development of
mammals. A few cases of threorunemia that might involve defects in threonine metabolism
have been reported in human. Recent clinical trials have demonstrated that administration
of Z-threonine to patients suffering from multiple sclerosis or familial spastic paraparesis can
alleviate their muscular
rigidity.34'35
Therefore, the research of TDH, the enzyme thought to be
the primary route for Z-threonine metabolism is of great interest.
Threonine metabolism follows three main routes in prokaryotes and eukaryotes (Fig. 6).
Threonine aldolase (EC 4.1.2.5) catalyzes the pyridoxal 5 -phosphate-dependent cleavage of
threonine with formation of glycine plus acetaldehyde.
Threonine dehydratase (EC 4.2.1.16) catalyzes the pyridoxal 5 -phosphate-dependent
deamination ofZ-threonine with production of 2-ketobutyrate (Fig. 6).
Threonine dehydrogenase (EC 1.1.1.103) is the most important enzyme involved in Z-
threonine metabolism (Fig. 6). It catalyzes the NAD+-dependent oxidation of threonine to form
an unstable intermediate, 2-amino-3-ketobutyrate, which either decarboxylates to form
aminoacetone which can be sterospecifically reduced to ZM-amino-2-propanol and incorporated
in vitamin B12 biosynthesis, or it can be converted to acetyl CoA plus glycine by the enzyme
aminoketobutyrate ligase (AKB ligase) in a coenzyme A dependent
reaction.37
Successively the
glycine may participate in serine biosynthesis in E.coli under certain environmental
conditions.38
TDH, therefore, initiates the conversion of Z-threonine into many metabolic intermediates and
plays amajor role in threonine metabolic pathways.
Threonine dehydrogenase activity is widespread and has been detected in
cell-free














TDH has been widely accepted as playing
the major role in initiating the metabolism of threonine in both prokaryotes and eukaryotes,
while the contribution of threonine aldolase or dehydratase to the degradation of Z-threonine is
relatively small.
TDH has been isolated in homogeneous form from six sources: E.coli, pig liver,
C.stricklandii, S. marcescens, goat and chicken liver. Some characteristics of these enzymes are




are each composed of only a single
polypeptide while that from C.
stricklandii42
and S. marcescens is dimeric. Those from pig
liver47
and E.coli are similar to each other in that they are both homotetrameric proteins. E.coli
TDH was the first to be purified to homogeneity. It was isolated from extracts of a constitutive
mutant strain ofE.coli K-12, which designated as SBD76. This mutant had elevated levels of the
enzyme as compared to wild type strain when grown on Z-threonine as the sole carbon
source.51
E.coli threonine dehydrogenase has been extensively characterized. It is composed of
four identical subunits (Mr= 148,000), each having 341 amino and a molecular weight of 35 kDa.
The purified E.coli K-12 enzyme showed Km values for Z-threonine and
NAD+
of 1.43 mM and
0.11 mM (in 50 mM Tris-HCl buffer pH 8.4 and 37C), respectively, while the Vmax was 34




increases the Vmax 9- or
24-fold, It only contains 1
Zn2+
atom/subunit.53
The substrate specificity of the
purified enzyme is broad: Z-threonine, Z-threonine amide, and D,Z-2-amino-3-hydroxypentanoic
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When E.coli tdh was cloned and sequenced, the deduced amino acid sequence showed
that TDH was homologous with members of the medium-chain, Zn2+-containing alcohol
dehydrogenase
family.54
The amino acid sequence of E.coli TDH is most similar to sheep liver
sorbitol dehydrogenase (SDH) and yeast alcohol dehydrogenase (28 and 27% identity,
respectively), while it has 25% identity with that of horse liver alcohol dehydrogenase (LADH)
and maize
ADH255
Fig. 7. presents an alignment of the primary amino acid sequence of these
enzymes with that ofE.coli TDH.
The ligands to the active site zinc of LADH are Cys-46, His-67 and Cys-174. Based on
computer modeling, it has been suggested that SDH also has a Cys-46, His-67 as ligands to the
catalytic zinc but differs from the LADH in having a glutamate, Glu-153 which aligns with
Cys-
174 in LADH (Fig. 7), as the third ligand; glu-153 in SDH aligns with Asp-148 from E.coli
TDH. Studies on the structures of horse liver alcohol dehydrogenase and its complexes with
NAD+
and substrate show two carboxyl groups near, but not directly ligated to, the active site
zinc . The carboxylate of Asp-49 forms a hydrogen bond to the imidazole of His-67, one of the
zinc ligands, whereas Glu-68 is located behind the metal ion, opposite the substrate binding site.






Glu-68 is conserved in E.coli TDH as well (which aligns to Glu-64 in E.coli TDH).
Such comparison suggests that the residues containing carboxyl group might be involved as
active zinc-ligands.
E.coli TDH is a homotetrameric protein which contains only one
Zn2+
ion per subunit and
the extendX-ray absorption fine structure (EXAFS) spectroscopic analyses suggests that it might
be a non-catalytic zinc which probably is bound by cysteine residues 93, 96, 99, and
107,59
comparable to the structural
Zn2+
of horse liver ADH.
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A few residues in E.coli have shown great importance in structure/function relationships.
Methylation of His-90 (which aligns with Thr-94 in horse LADH55) with methyl
p-
nitrobenzenesulfonate60
and site directed mutagenesis of this residue both suggested that His-90
may play a role in substrate
recognition.28
TDH activity was abolished by j>-mercuribenzoate
and
iodoacetate,61
the residue modified was determined to be
Cys-3853
and site directed
mutagenesis confirmed that Cys-38 as a probable ligand to the zinc.
The goal of the research presented in this thesis is to investigate the role of Glu-88 in
reaction catalyzed by TDH by constructing a site-directed mutant enzyme, TDH E88C (Glu-88
to Cys-88). The thesis focuses on generating the mutant form of the enzyme, then purifying it to
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LADH : SGTLV-TPLPVIAGHEAAGIVESIGEGVTTVRPGDKV- IPLFTPQCGKCRVCKHPE
1 10 120 130 1 40 1 50 1 60
TDH : THLCRNT IGVGV NRPGCFAEYL-VIPAFNAF-KI
SDH:YNLSPTI--F FCATP PDDGNLCRFY-KHNANFCY-KL
YADH : ESNC PHADLSG YTHDGSFQQYATADAV- -QAAHI
MADH : SNMCDLLRINVDRGVMIGDGKSRFTISGQPIFHFVGTSTFSEYTVIHVG- -CLAKI
LADH : GNFCLKNDL-SMPRGTMQDGTSRFTCRGKPIHHFLGTSTFSQYTWDEI - - SVAKI
170 180 19 0 200 210
TDH : PDNISDDLAAIF-DPFGNAV-HTALSFDL-VGEDVLVSGA-GPIGIMAAAVAKHVG




22 0 23 0 240 25 0 26 0 2 70
TDH : ARNVVITDVNEYRLELARKMGITRAVNVAKENLNDVMAELG- -MTEGFDVGLEMSG
SDH:AAQVVVTDLSASRLSKAKEVGADFILEISNESPEEIAKKVEGLLGSKPEVTIECTG
YADH : - YRVLGIDGGEGKEELFRSIGGEVFIDFTKEKDIVGAVLKATDG- -GAHGVINVSV
MADH :ASRIIGVDINPAKYEQAKKFGCTEFVN- PKDHDKPVQEVLIELTNGGVDRSVECTG
LADH :AARI IGVDINKDKFAKAKEVGATECVN-PQDYKKPIQEVLTEMSNGGVDFSFEVIG
28 0 290 3 00 31 0 320
TDH :APPAFRTMLDTMNHG-GRIAMLGIPPSD- -MSIDWTKVTFKGLFIKGIY- -GREMF
SDH :VETSIQAGIYATHSG-GTLVLVGLGSEM- -TSVPLVHAATREVDIKGVF RYC
YADH : SEAAIEASTRYVRAN-GTTVLVGMPAGAKCCSDVFNQ-WKSISIVGSY VGNR
MADH:NVNAMISAFECVHDGWGVAVLVGVPHKDDQFKTHPMN-FLSEKTLKGTFFGNYKPR
LADH : RLDTMVTALSCCQEAYGVSVIVGVPPDSQNLSMNPML-LLSGRTWKGAIFGGFKSK








Figure 7. Amino acid sequence comparison of several alcohol dehydrogenases. E.coli threonine
dehydrogenase (TDH); SDH (sheep liver sorbitol dehydrogenase); YADH (yeast alcohol dehydrogenase,
isozyme 1); LADH (horse liver alcohol dehydrogenase, isozyme E). The numbers correspond to the
LADH sequence. Residue numbers are for the amino acid corresponding to the last digit of the number28.
The bold letters are conserved sequences and the bold underlined amino acids show the conserved
carboxyl groups that might be involved in the active zinc binding site.
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MATERIALS
Materials used for culturing E.coli SPI 192 pAJWT cells were purchased from the
sources listed: E.coli spi 192 pAJWT stock was a generous gift of Professor Eugene E. Dekker
from the University ofMichigan Dept. ofBiological Chemistry; bacto-yeast extract from Becton
Dickinson; bacto-tryptone from DIFCO Laboratories; glycerol from J.T.Baker; and ampicillin
from Sigma.
General chemicals used routinely were reagent-grade products of the companies
indicated: potassium dihydrogen phosphate, potassium hydrogen phosphate, sodium hydroxide,
potassium chloride, hydrochloric acid, methanol, acetic acid, calcium chloride and sodium azide
from J.T.Baker; Trizma hydrochloride, Trizma base and 2-mercaptoethanol from Sigma; efhanol
fromAAPER Alcohol and Chemical CO.
The BIGGER prep Plasmid DNA Preparation Kit was purchased from 5 Prime> 3
Prime, Inc. The components included: Solution I (buffered RNase A solution), solution II
(alkaline lysis solution), solution m (potassium acetate solution), DNA binding matrix
suspension in guanidine-HCl, buffered salt solution, TE (pH 8.0) and sodium chloride.
The
QuikChange Site-Directed Mutagenesis Kit was purchased from Stratagene,
materials provided: Pfu DNA polymerase, lOx reaction buffer, Dpn restriction enzyme,
oligonucleotide control primer #1, oligonucleotide control primer #2,
pWhitescript
4.5-kb
control plasmid, dNTP mix, Epicurian Coli XL-Blue supercompetent cells and pUC18 control
plasmid. Additional materials required: X-gal and JPTG from Life Technologies. All the
oligonucleotide primers were synthesized at the University of Rochester Core Nucleic Acid Lab.
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ABI PRISM dye terminator pre-mix DNA sequencing reagents were from
Perkin-
Elmer Corporation.
QIAprep Spin Miniprep Kit was ordered from QIAGEN. Reagents provided: RNase A,
buffer Pi, buffer P2, buffer N3, buffer PB and buffer PE.
The materials used in the purification of threonine dehydrogenase were purchased from
the companies noted: Poros 50 DEAE weak anion exchange packing and HQ high capacity
strong anion-exchange column from PerSeptive Biosystems; Cibracron Blue F3GA from Sigma;
and TOYOPEARL HW-55S from Superlo, Inc.
Chemicals for agarose gel electrophoresis and polyacrylamide gel electrophoresis were
purchased from the following resources: standard low electroendosmosis agarose, ammonium
persulfate, SDS, sodium acetate, tris-acetate and EDTA from J.T.Baker; 30% acrylamide/Bis
solution, TEMED, glycine, Coomassie blue stain, SDS-PAGE low range molecular weight
standards, ethidium bromide and bromophenol blue from Bio-Rad Laboratories; lkb DNA ladder
fromNew England Biolabs, Inc, and DNA loading dye from Carolina Biologicals, Inc.
Reagents for protein and activity assays were purchased from the following companies:
protein assay dye reagent concentrate from Bio-Rad Laboratories; bovine gamma-globulin from
Worthington Biochemical Corporation; threonine from J.T.Baker; NAD+, phenazine
methosulfate and p-iodotetrazolium violet from Sigma.
Instrumentation used for experiments were from the sources listed: SORVALL RC 5C
Plus centrifuge and SLA-1500 and SA-600 rotors were from Dupont; Centra-CL2 centrifuge
from International Equipment Company; desktop Biofuge 13 from Heraeus Instruments;
Sonifier sonicator from Branson Instruments, Inc; GeneAmp PCR System 2400 from Perkin
Elmer;
Waters 650 protein purification system and 486 tunable absorbance detector from
17
Waters; fraction collector (model FC 205) from Gilson; 37C water bath, 37C incubator, -85C
freezer from VWR Scientific; UV-VIS spectrophotometer model 8543 from Hewlett Packard;
microplate reader from DYNEX Technologies; electrophoresis assemblies and electrophoresis
power supply (model PAC 300) from Bio-Rad.
18
EXPERIMENTALMETHODS
1. Growth ofE.coli cells containing pAJWT plasmid
E.coli SPI 192 is a
tdh"
strain in which the gene coding for chloramphenicol acetyl
transferase (CAT) has been inserted into tdh gene. The TDH gene has been cloned into a
plasmid called
pDR12138
and then genetically subcloned to the plasmid pAJ (sometimes called
pTDH). This plasmid also contains the gene for ampicillin resistance that is an important feature
for bacterial selection when grown on media containing ampicillin. The plasmid containing the
wild type tdh gene is called pAJWT.
E.coli SPI 192 pAJWT stock cells were grown in LB containing 60 |lg/mL ampicillin,
diluted with an equal volume of sterile glycerol and stored at -82C. One aliquot was thawed and
maintained at -20C for use. Luria Broth (LB) was prepared as
indicated:63
10 g NaCl, 5 g
bacto-
yeast extract, 10 g bacto-trptone were dissolved in one liter of deionized water and sterilized by
autoclaving. LB-ampicilhn agar plates were prepared as follow: the liquid LB medium was
prepared according to the recipe given above, but before autoclaving, 15g/liter bacto-agar were
added. After autoclaving, broth and plate media were allowed to cool to
50
before adding
60|lg/mL of ampicillin. Finally the medium was poured to plates when it was cool. Terrific Broth
(TB) was prepared as follows: 12 g bacto-tryptone, 24 g bacto-yeast extract, and 4mT, glycerol
were dissolved in 900 mL deionized water and autoclaved. 2.31 g KH2P04 and 12.54 g K2HP04
were dissolved in 100 mL ddH20 and autoclaved in a separate flask. The two solutions were




A 50 mg/mL ampicillin solution was prepared and sterile filtered (0.22 |Lim sterile filter
disk) and stored at 4C. Ampicillin (6 |il of 50 mg/mL stock) was added to 5 mL of LB media; 5
|il of E.coli SPI 192 pAJWT stock were then inoculated into the same media. The cells were
incubated in a 37C shaker for 16 hours. Ampicillin (0.6 mL of 50 mg/mL stock) was added to
500 mL TB that was inoculated with 5 mL of E.coli SPI 192 pAJWT culture. The cells were
incubated in a 37C shaker overnight with vigorous shaking and harvested by centrifugation at
10,000 x g for 10 min using RC-5C Plus centrifuge equipped with a SLA 1500 rotor. Supernatant
was decanted and the cell paste was transferred to a 50 mL conical centrifuge tube and stored at
-20C in a non-defrosting freezer. The wet weight of the cells was recorded.
2. Site-directed mutagenesis of threonine dehydrogenase in E.coli using PCR
2.1. Plasmid DNA preparation
The BIGGERprep Plasmid DNA Preparation Kit was used to isolate the plasmid
pAJWT. The cell pellet from 5 mL of cells grown overnight in LB containing 60 |lg/mL
ampicillin was completely suspended in 15 mL of supplied Solution I (buffered RNase A
solution), then 23 mL Solution n (alkaline lysis solution) was added and mixed well until the
lysate looked clear with no visible clumps. The bacterial lysate was neutralized by adding 1 1 mL
Solution m (potassium acetate solution) and mixed by gentle inversion until white material was
broken into small clumps. Then the mixture was centrifuged at 23,000 x g for 5 min and the
supernatant was carefully transferred to a fresh centrifuge bottle. 40 mL of well-mixed
BIGGERprep DNA BindingMatrix Suspension was added to the recovered supernatant above to
efficiently bind the plasmid DNA. The mixture
in the centrifuge bottle was centrifuged at 23,000
x g for 5 min and the supernatant was
decanted. Diluted Purification Solution (10 mL) was added
to the pellet and mixed well by vigorous shaking (75 mL of Purification Solution Concentrate
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was diluted with 75 mL of 95% efhanol). The mixture was poured into a BIGGERprep Spin
Column that had been inserted into a 50 mL conical centrifuge tube. Another 10 mL diluted
Purification Solution was added to the centrifuge bottle to wash the residual matrix from bottle
sides. The wash was poured into the same BIGGERprep Spin Column. The Spin
Column/centrifuge tube assembly was centrifuged at 2,000 x g for 5 min. Then 10 mL more of
the diluted Purification Solution was added to the same BIGGERprep Spin Column to further
purify the bound plasmid DNA and centrifuged at 2,000 x g for 5 min. Then the BIGGERprep
Spin Column was transferred to a fresh, sterile, 50 mL conical centrifuge tube. The purified
plasmid DNA was eluted by 3 mL TE, pH 8.0 and centrifuged at 2,000 x g for 5 min. The eluted
purified plasmid DNA was carefully transferred to the provided
"precipitation"
tube and 70 jxL 5
M NaCl were added followed by 6 mL 95% efhanol. The mixture was centrifuged at 16,000 x g
for 5 min. The pellet was washed with 70% efhanol twice and air-dried. After the pellet was dry,
the pellet was resuspended in 1 mL nanopure water and stored at 4C. DNA agarose gel
electrophoresis was carried out to evaluate the extraction.
The concentration of the isolated plasmid was determined by UV-VIS spectrophotometer.
The plasmid was diluted 100-fold in ddH20. The spectrum was taken and the absorbance values
at 280 and 260 nm were recorded. The concentration of the plasmid DNA was estimated using
A26o=LO for 50 |lg/mL of plasmid DNA solution. The ratio of A260/A28o was used to evaluate the
presence of protein in the plasmid preparation; a ratio > 1.8 indicated acceptable removal of
proteins.
2.2 Preparation of oligonucleotide primers
Two primers were prepared by the University of Rochester Core Nucleic Acid Lab using
Nucleic Acid Synthesis System ABI 392 and ABI
Masterpiece
reagents from Perkin Elmer
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Corporation. They were complementary to opposite strands of the double-stranded plasmid DNA
template and contained the changes of the codon for residue 88 of TDH from Glutamate (5'-
GAA) to Cysteine (5'-TGC, see Figure 9). The primer sequence (mutation points are underlined)










The site-directed mutagenesis PCR protocols below were from Stratagene QuikChange
Site-DirectedMutagenesis Kit.
2.3. Setting up the mutagenesis reactions for PCR
A control reaction was prepared as indicated below: 5 |lL of lOx reaction buffer, 2 |iL of
pWhitescript 4.5-kb control plasmid (5 ng/LiL), 1.25 fjL of oligonucleotide control primer #1
(100 ng/flL), 1.25 (lL of oligonucleotide control primer #2 (100 ng/iiL), 1 (iL of dNTP mix and
double-distilled water (ddH20) to a final volume of 50 uX. Reaction buffer (lOx) consisted of
100 mM KC1, 100 mM (NH4)2S04, 200 mM Tris-HCl (pH 8.8), 20 mMMgS04, 1% Triton X-
100 and 1 mg/mL nuclease-free bovine serum albumin. The sample reaction contained the
following components: 5 p:L of lOx reaction buffer, varying concentrations of pAJWT DNA
template (5 ng, 10 ng, 100 ng) for each reaction tube, 125 ng of the two oligonucleotide primers,
1 U.L of dNTP mix to a final volume of 50 ui. Pfu DNA polymerase (2.5 U) was added to both
of the reaction mixtures.
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2.4 Cycling the reaction
The following program was cycled 16 times and kept at 4C until removal.
Segment Cycles Temperature Time
1 1 95C 30 seconds
2 16 95C 30 seconds Denaturation
55C 1 minute Annealing
68C 10 minutes Elongation
2.5. Digesting the products
Following the PCR reaction, Dpn I restriction enzyme (10 U) was added to each
amplification reaction tube and mixed thoroughly. The reaction mixtures were then centrifuged
for 1 minute and immediately incubated at 37C for 1 hour to digest the parental double stranded
DNA. The Dpn I endonuclease can recognize and digest the C-6 methylated guanine in the target
sequence 5'-Gm6ATC-3, so the parental DNA template is cut into pieces and leaves the
mutation-
containing synthesized DNA intact.
2.6. Transforming into Epicurian coli SLl-Blue supercompetent cells
One U.L Dpn I-treated DNA from the control and sample reactions was added to separate
50 |lL aliquots of the supercompetent cells provided. The reaction tubes were incubated on ice
for 30 minutes. Then the reactions were heat shocked for 45 seconds at 42C, followed by
placing them on ice for 2 min. 0.5 mL of LB broth preheated to 42C was added to each reaction
tube and incubated at 37C for 1 hour with shaking. 250 uL of the control transformation reaction
was plated on LB-ampicillin agar plate that had been spread with 20 \\L of 10% (w/v) X-Gal and
20 (iL of 10 mM IPTG. The entire volume of the sample reaction was plated on LB-ampicillin
agar plate. All the plates were incubated at 37C overnight.
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3. Agarose gel electrophoresis ofDNA
Agarose (0.8%) was prepared in TAE buffer (40 mM tris-acetate, 20 mM sodium acetate,
ImM EDTA, pH 8.0). A lkb ladder was used as standard. DNA samples at various stages of the
experiments were analyzed. The gel was run at 100 V for about 1 hour until the tracking dye
approached the end of the gel. Then the gel was stained in 0.2 |ig/mL ethidium bromide for 15
min and destained with distilled water. A picture of the gel was taken on the UV light box by
Kodak digital camera (Model DC40) connected to a ZEOS 486 computer running Windows NT
4.0. The picture was analyzed and printed using Kodak Digital Science ID software (Figure 10).
4. Growth ofEpicurian Coli SLl-Blue cells containing PCRmutated plasmid
Randomly twenty colonies from the LB-ampicillin plate containing the sample reaction
which started with 10 ng DNA template concentration in the PCR reaction mix were selected and
sterilely inoculated in separate tubes containing 5 mL LB media with 60 (ig/mL ampicillin. The
cells were cultured overnight on the 37C shaker. Cells (0.5 mL from each of 5 mL culture tubes)
were diluted in equal volume of sterile glycerol and frozen in liquid nitrogen and then kept in -
85C freezer for long term storage.
5. Isolation ofPCRmutated plasmid from Epicurian Coli SLl-Blue cells
The QIAprep Plasmid Preparation Kit was used for plasmid isolation. All centrifugation
steps for the miniprep were performed on Heraeus microfuge at maximal speed (10,000 x g or
13,000 rpm). Randomly six of the twenty 4.5 mL overnight cultures from procedure 4 were
selected for further experiments. They were centrifuged at 13,000 rpm in a centrifuge for 5 min.
Kit reagents were prepared according to the manufacturers specifications: the supplied RNase A
was diluted in 2 mL ddH20 and then added to Buffer PI and stored at 4C; an equal amount of
95% efhanol was added to Buffer PE.
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The cell pellets were resuspended in 250 |iL Buffer PI and transferred to microfuge
tubes. Buffer P2 (250 uL) was added to each tube and gently inverted 4-6 times to mix. Then 350
aL of Buffer N3 was added and the tubes were inverted immediately but gently 4-6 times until
the solution became cloudy and very viscous. All the tubes were centrifuged for 10 min and a
compact white pellet formed. The QIAprep spin columns were placed in 2 mL collection tubes
and the supernatants were applied to the QIAprep column assemblies. They were centrifuged for
60 sec and the filtrates were discarded. QIAprep spin columns were washed by 0.5 mL Buffer
PB and centrifuged for 60 sec. 0.75 mL of Buffer PE was added to each QIAprep spin column
and centrifuged for 60 sec. QIAprep spin columns were centrifuged for an additional 1 min to
remove residual wash buffer. Then QIAprep spin columns were placed in clean 1.5 mL
microfuge tubes and 50 jiL TE buffer was added, the assemblies were centrifuged for another 1
min after standing for 1 min. The filtrates containing the plasmids were collected in separate
microfuge tubes.
6. Cycle sequencing to evaluate the tdh gene of the PCRmutated plasmid
The protocol was taken from the ABI PRISM Dye Terminator Cycle Sequencing Ready
Reaction
Kit.65
The four sequencing primers were synthesized at the University of Rochester
Core Nucleic Acid Laboratory. The positions where they will anneal to the tdh template are
shown on Figure 8. The sequence of two external primers were: 031, 5'-
ACGCGTGCAGTAGAAGCAATTTACGCG-3'; 030, 5'-CGCGTGCAGTAGAAGC
ATTTACGCG-3'. The sequence of two internal primers were: 636, 5'-
GTCGTGGGCCATGAATATGT-3'; 103, 5'-CGATAGACATATCAGACGGC-3'.
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TDH gene of E.Coli
(TDH gene starts from 1704-2760)
1501 cggtagtggc gcagaaattt gcccgtgagc tgcaaaaaga gggcatttac gttaccggtt
1561 tcttctatcc ggtcgttccg aaaggtcagg cgcgtattcg tacccagatg tctgcggcgc
1621 atacccctga gcaaattacg cgtgcagtag aagcatttac gagtattggt aaacaactgg
Primer 031(1639-1663)
1681 gcgttatcgc ctgaggatgt gagatgaaag cgttatccaa actgaaagcg gaagagggca
1741 tctggatgac cgacgttcct gtaccggaac tcgggcataa cgatctgctg attaaaatcc
1801 gtaaaacagc catctgcggg actgacgttc acatctataa ctgggatgag tggtcgcaaa
























































2 7 01 ccgggaaagt
2761 tatctgagga
2821 tgtgctgatc
gatctttaaa ggcttgttca ttaaaggtat ttacggtcgt gagatgtttg
caagatggcg gcgctgattc agtctggcct cgatctttcg ccgatcatta
ctctatcgat gatttccaga agggctttga cgctatgcgt tcgggccagt
tattctgagc tgggattaac acgaacaagg gctggtattc cagccctttt
taatctgtta aatatgtaaa atcctgtcag tgtaataaag agttcgtaat
tcttatatag ctgctctcat tatctctcta gggtgaagtg actctctcac
Primer 030 (2865-2840)
Figure 8. The complete sequence of the tdh gene from E.coli (bold) and positions of four sequencing
primers (above arrows).
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Each sequencing reaction consisted of 8.0 (J.L Terminator Ready Reaction Mix
(double-
stranded plasmid DNA 0.4 jj,g, primer 3.2 pmole and ddH20 to a total volume of 20 (iL). It was
cycled on the GeneAmp PCR system 2400. The thermal cycling was begun as follows:
Rapid thermal ramp to 96C
96C for 10 sec
Rapid thermal ramp to 55C
55C for 5 sec
Rapid thermal ramp to 62C
62Cfor4min
The thermal cycle was repeated for 25 cycles and kept at 4C until removal. The reaction
tubes were sent to University ofRochester Core Nucleic Acid Laboratory for DNA sequencing.
7. Expression of the mutated gene of threonine dehydrogenase in E.coli
These protocols were taken fromMolecular Cloning: A LaboratoryManual.
7.1. Competent E.coli SPI192 cells preparation
An overnight culture of E.coli SP1192 cells (1 mL) was aseptically transferred to 100 mL LB
media and incubated for 6 hours at 37C shaker with vigorous shaking. Then 25 mL of the cell
culture were aseptically transferred to a sterile, ice-cold 50 mL disposable polypropylene tubes
and stored on ice for 10 min. The cells were recovered by centrifugation at 4000 rpm for 10 min
at 4C. The pellet was resuspended in 5 mL of ice-cold 0. 1 M CaCl? and stood on ice for 10 min.
The cells were centrifuged again, and the tubes were drained thoroughly. The pellet was
resuspended in 1 mL of ice-cold 0.1 M CaCl2.
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7.2. Transformation of competent cells
100 \iL of competent cell suspension from the above procedure were transferred to a
sterile microfuge tube using a chilled, sterile pipette tip. 500 ng PCR mutated plasmid DNA was
added to the tube. It was placed in a 42C water bath for exactly 90 sec. Then the tube was
rapidly transferred to an ice bath for 1 min. LB (400 |iL) containing 60 lig/mL ampicillin was
added to the tube and the tube was incubated for 45 min in 37C water bath. 200 jiL transformed
competent cells were spreaded onto the LB-ampicillin agar plate.
8. Purification of threonine dehydrogenase from extracts ofE.coli SP1192 pTDH E88C
8.1. Growth ofE.coli SPI192 pTDH E88C cells.
One colony from the above LB-ampicillin agar plate was picked up sterilely, then
cultured and harvested as described previously in p20.
8.2. Preparation of the crude extract from E.coli SP1192 pTDH E88 cells
E.coli cells were resuspended in cold 0.05 M tris-HCl, pH 8.4 (0.5 mM 2-
mercaptoethanol and 0.02% NaN3 were added to all buffers). Two mL of buffer was used for
each gram of cells. The cell membranes were fractured by sonic oscillation in the Branson
sonicator in 2 min burst for each 5 g of cells (the cells were kept in an ice bath to maintain the
temperature at or below 10C). The resulting homogenate was centrifuged at 20,000 xg for 30
min. The supernatant was filtered by Acrodisc PF 0.8/0.2 |im two-stage filter and stored at 4C.
A 0.5 mL aliquot was saved in the -20C freezer for later analysis.
8.3. First step ofpurification : gel filtration chromatography
A gel filtration column was prepared by gravity packing TOYOPEARL HW-55s media
into aWaters AP-2 (2 cm ID x 60 cm) column, which was connected to aWater 650E Protein
Purification System. Crude extract (5 mL) was injected for each run. The buffer was 20 mM tris
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pH 8.5 containing 0.1 M KC1. The flow rate was set at 1 rnlVmin. Threonine dehydrogenase
activity was determined by colorimertric microplate assay. Active fractions were pooled together
and a 0.5 mL aliquot was saved at -20C freezer for analysis.
8.4. Second step of purification: dye-ligand affinity chromatography
A dye-ligand affinity chromatography column was prepared by gravity packing Cibacron
Blue F3GA (Reactive Blue 2 Sepharose) into aWaters AP-2 (1cm ID X 10 cm) column which
was connected to Water 650E Protein Purification System. The flow rate was maintained at 2
rnlVmin. The gel filtration pool (1 mL) was applied to the column at pH 7.5. Then the column
was washed with Tris buffer (pH 7.5) until the absorbance (A^280 nm) returned to baseline. In
order to elute TDH activity, 5 mL pH 8.5 0.02 M Tris buffer containing 5mM
NAD+
was washed
through the column. TDH activity was assayed by colorimertric microplate assay and active
fractions were pooled together. A 0.5 mL aliquot was saved at -20C freezer for later analysis.
8.5. Third step of purification: ion exchange chromatography
A Poros 50 HQ (10 mm ID X 50 mm) High Capacity Strong Anion Exchange Column
was used for this last step of purification. Before applying the sample to the column, the fraction
pool from Cibacron Blue F3GA was concentrated using AMICON CENTRIPLUS
Concentrators and centrifuged at 3000 x g for 125 min. The concentrated sample was applied to
the Poros HQ column at 1 ml volume each run.
The program gradient is shown below:
? Reservoir A is a 100 mM solution of the acid form of the buffer (e.g., Tris-HCl)
? Reservoir B is a 100 mM solution of the base form of the buffer (e.g., Tris).
? Reservoir C is 2 M KC1
? Reservoir D is nanopure water.
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Time (min) Flow (mL/min) %A %B %C %D
initial 4 6 14 0 80
5 4 6 14 0 80
6 4 6 14 5 75
7 4 6 14 5 75
12 4 6 14 10 70
13 4 6 14 10 70
18 4 6 14 15 65
20 4 6 14 15 65
25 4 6 14 20 65
26 4 6 14 20 65
30 4 6 14 80 0
40 0 6 14 80 0
9. Determination of enzyme homogeneity by SDS-PAGE
Polyacrylamide gel electrophoresis was carried out to determine the homogeneity of
samples saved from each purification step. The samples were diluted with an equal volume of 2x
Laemmli (1 mL 0.5 M Tris-HCl (pH 8.8) solution: 4 mL distilled water, 0.8mLglycerol, 1.6mL
10% SDS, 0.4 mL 2-mercaptoethanol and 0.2 mL of 0.5% bromophenol blue). The gel consisted
of a 10% acrylamide separating gel and a 4% stacking gel. Electrophoresis was carried out in
Tris-glycine-SDS buffer (0.3% Tris base, 1.45% glycine, 0.1% SDS, pH 8.0) at 200 volts for
about 40 min until the tracking dye reached the bottom of the gel. The gel was stained in
Coomassie Blue stain solution which consisted of 40% methanol, 10% acetic acid, 50% ddH20
and 0.1% (w/v) Coomassie Blue for 1 hour, then destained in 40% methanol, 10% acetic acid
and 50% water for several hours until Coomassie blue stain was gone. Relative migration (Rm)
was determined by dividing the migration distance of the protein bands by that of the tracking
dye.
10. Protein determination
Protein concentration in solution was determined using the Bio-Rad version of the
Bradford dye-binding
assay.66
Bovine gamma globulin served as standard and a calibration curve
was prepared. The Dye Reagent Concentrate was diluted 1 :4 with ddH20 and filtered through a
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Whatman #1 filter to remove particles. Crude extract and aliquot samples saved from each
purification step were mixed with water to a total volume of 150 |iL in all tubes (the dilution and
volume of each sample was ajustified to give the absorbance reading falling in the range of the
calibration graph). Then 5 mL of diluted dye reagent was added to each tube and vortexed well.
The mixtures were incubated at room temperature for 5 min. Absorbance values at 595 run were
measured for all the samples using a disposable cuvette by a
UV-Visible spectrophotometer. The
concentration of the TDH for each sample was determined based on the calibration curve.
11. Specific assays for threonine dehydrogenase activity
Threonine dehydrogenase activity was assayed by one of two methods. A colorimetric
fin
microplate assaywas done routinely to detect TDH activity throughout the purification process.
The assay solution consisted of 0.2 M Tris-HCl (pH 8.4), 0.125 M Threonine, 5 mM NAD+, 5
(ig/mL phMS, 200 (ig/mL pTTV. 150 (lL assay solution was added to wells in a microliter plate
that contained 50 U.L of sample. Then a microplate reader followed the AA490 for 6 minute.
Activity was also detected by visual inspection of the pink color produced in the presence of
threonine dehydrogenase activity.
The second assay followed the formation of NADH at 340 run due to the enzymatic
oxidation of threonine. This assay was used in studies with aliquot samples saved after each
purification step and crude extract to determine the specific and total activity of the enzyme. The
assay solution consisted of 0.2M Tris-HCl (pH 8.4), 0.125 M Threonine and 5 mM NAD+. Then
Assay solution (1 mL) was added to each of the disposable polystyrene cuvettes containing
enzyme solution (10-50 |iL) and linear reaction rates were observed for the first 5-6 minutes at
37C. A series of enzyme dilutions was assayed to ensure that the rate of the reaction is
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1. Site-directed mutagenesis of threonine dehydrogenase in E.coli using PCR
Site directed mutagenesis is a process whereby a single amino acid substitution can be
made in the sequence of an enzyme by changing the sequence of the gene that codes for that
amino acid without modifying the remainder of the primary sequence of the enzyme. It is a
powerful technique in better understanding the role of the original amino acid in the enzyme's
function and structure.
Our overall goal is to determine the possible role of the glutamate 88 in the reaction
catalyzed by threonine dehydrogenase in E.coli. Therefore, a mutant E88C (replacement of
glutamate 88 with cysteine) was constructed by site directed mutagenesis using PCR technology.
The two primers containing the single point mutation are shown on Figure 9. The
QuikChange
Site-Directed Mutagaenesis Kit was used to generate the mutagenized TDH plasmids.
The mutagenesis reaction consists of the plasmid containing the native tdh gene, two
primers with a single point mutation of glutamate 88 to cysteine, pfu polymerase, dNTPs and
reaction buffer containingMg +. The mutagenized plasmids were used to transform the supplied
Epicurian coli XLl-Blue Supercompetent Cells and streaked on LB-ampicillin plates.
The pWhitescript control plasmid was used to test the efficiency of mutant plasmid
generation. It is done by using LB-Amp medium that has been treated with IPTG (an inducer of
P-galactosidase expression) and X-gal (a chromogenic substrate for p-galactosidase). Colonies
expressing a functional P-galactosidase will appear blue on plates coated with IPTG/X-gal.
Colonies without the functional enzyme will be white on the same plates. The pWhitescript
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control plasmid is (p-galactosidase gene is defective). Epicurian coli XL 1-Blue
supercompetent cells transformed with this control plasmid appear white on plates, because
P~
galactosidase activity is not present. The oligonucleotide control primers create a point mutation
that reproduces the P-galactosidase gene in the template during PCR amplification. Colonies
transformed with the mutated
gal+
plasmid are blue phenotype.
Our result showed that greater than 80% of the control colonies contained the mutation
and appeared as blue colonies on LB-ampicillin agar plates, containing IPTG and X-gal. The
sample reaction that contained 0.2 (Ig/mL of template, 2.5 (Ig/mL of each of the two primers
(refer to p. 23 for the contents of other components in the reaction) resulted in the growth of
about 200 colonies on LB-ampicillin plates. In similar reactions that used 0.1 (Xg/mL or 1 [ig/mL









Figure 9. Linear version of pTDH and sequences of two mutagenic primers. The bold letters show the
codon for glutamate-88 on TDH, bold italic letters show the pointmutation coding for cysteine in the
mutagenic primers.
34
2. Agarose gel electrophoresis ofDNA
Agarose gel electrophoresis (0.8% agarose) showed the existence of DNA at various
stage of the experiment (Figure 10). There were impurities on the lanes containing wild type
(lane 3) and mutagenized plasmid TDH (lane 5), but none in the PCR product (lane 4).
Traditionally, PCR has been used to create an exponential amplification of a target DNA
segment, with all the products of one cycle acting as template for the next cycle. In the
QuikChange Site-Directed Mutagaenesis Kit, the concentration of the mutagenized plasmid
was increased linearly instead of exponentially during PCR because the design of the two
primers (Fig. 9) allowed the replication of only the parental strands to take place in each
successive round. Therefore, the mutagenized plasmid products were present at low level even
after PCR (Figure 10, lane 4). To show the weak PCR band, the gel was taken under
overexposed condition.
1









Figure 10. Agrose gel eletrophoresis analysis of various DNA sample. Samples of interest were: lane 1:
1 kb ladder DNA standard; lane 2, A/HindUI standard; lane 3: plasmid pAJWT; lane 4: PCR mutagenized
plasmid TDH; lane 5: mutagenized plasmid isolated from E.coli SPI 192 after transformation.
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3. Cycle sequencing of tdh gene to evaluate the PCR mutagenized plasmid
The positions of the four sequencing primers where it annealed to the template plasmid
during PCR are shown on Fig. 8. The sequencing data from University of Rochester Nucleic
Acid Laboratory were submitted to BLAST at National Center for Biotechnology
information69
for best matching sequences. The sequencing results with each of the primers are shown in Fig.
11,12, 13 and 14.
BLAST (Basic Local Alignment Search Tool) is a set of similarity search programs
designed to explore all of the available sequence databases regardless of whether the query is
protein or DNA. The paragraph before the actual sequence alignment gives the information about
the high-scoring segment pairs (HSPs) and some statistical significance between the submitted
sequence and database sequence (Expect value is a parameter that tells the number of times one
might Expect to see a match simply by chance, P value is the probability of observing a match,
ranging from 0-1. When the Expect value is increased from the default value of 10, a larger list
with more low-scoring hits can be reported). Query refers to the sequence submitted and sbj ct
refers to database sequence. Vertical lines mean the exact match between the submitted sequence
and the database sequence; no line means no match. The letter N means ambiguity in the query
sequence, as obtained from the University ofRochester Nucleic Acid Laboratory.
E.coli tdh database sequence is numbered 1704 to 2729. Primer 031 read about 550 bases
from 1704 to 2254 that contained the point mutation Glu-88 (GAA) to Cys (TGC). There were
ambiguities at positions 2033 and 2199 that were confirmed to be G and G respectively by using
primer 636. Primer 636 read sequence from 1939 to 2333 (394 bases length) which also
contained the point mutation without any ambiguity. Primer 103 read 399 bases from 2066 to
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2465 with one ambiguity 2150 that was confirmed to be the right base (C) by primer 636. Primer
030 read 290 bases from sequence 2439 to 2729 (where tdh gene ends) without anymismatch.
In summary, by using four primers the whole tdh gene of the mutant plasmid were
sequenced, the tdh gene was intact with only the expected single point mutation Glu-88 (TGC) to
Cys (GAA). To confirm these results DNA sequencing was repeated using plasmid isolated from
transformed E.coli SPI 192 (tdh").
Figure 11. Sequence data from tdh 1704-2254 using primer 031
emb|X06690|ECKBLTDH E. coli genes tdh and kbl
Length = 3563
Plus Strand HSPs:
Score = 2326 (642.7 bits), Expect = 1.3e-215, Sum P(2) = 1.3e-215
Identities = 468/472 (99%), Positives = 468/472 (99%), Strand = Plus / Plus
Query: 3 6 TGAGATGAAAGCGTTATCCAAACTGAAAGCGGAAGAGGGCATCTGGATGACCGACGTTCC 95
IIIIIMIIMIMMIMIIIIIIIIIIIMIIIIIIIIIMMIIMIIIIMIIIII
Sbjct: 1700 TGAGATGAAAGCGTTATCCAAACTGAAAGCGGAAGAGGGCATCTGGATGACCGACGTTCC 1759
Query: 96 TGTACCGGAACTCGGGCATAACGATCTGCTGATT7AAAATCCGTAA7AACAGCCATCTGCGG 155
MIMIIIIMIIIIMIIIIIMIIIIMMMIIIIIMIIIIIIIIMIIIIIIIII
Sbjct: 1760 TGTACCGGAACTCGGGCATAACGATCTGCTGATTAAAATCCGTAAAACAGCCATCTGCGG 1819
Query: 156 GACTGACGTTCACATCTATAACTGGGATGAGTGGTCGCAAAAAACCATCCCGGTGCCGAT 215
IIIIIMIIIIIMIIIIIIMIIMMIIIIIIIIIIIIIIIIIIIIMIMIIIIIM
Sbjct: 1820 GACTGACGTTCACATCTATAACTGGGATGAGTGGTCGCAAAAAACCATCCCGGTGCCGAT 1879
Query: 216 GGTCGTGGGCCATGAATATGTCGGTGAAGTGGTAGGTATTGGTCAGGAAGTGAAAGGCTT 275
1 1 ; 1 1 1 1 1 1 1 1 1 1 1 [ i ; 1 1 f j 1 1 1 ! 1 1 1 1 1 1 f 1 1 1 i 1 1 1 1 f 1 1 1 [ i [ j 1 1 i i i i 1 1 1 1 1 [
Sbjct: 1880 GGTCGTGGGCCATGAATATGTCGGTGAAGTGGTAGGTATTGGTCAGGAAGTGAAAGGCTT 1939
Query: 276 CAAGATCGGCGATCGCGTTTCTGGCJGqGGCCATATCACCTGTGGTCATTGCCGCAACTG 335
I II I I I I I II I I I I I I I I I I I II I
.
I I I I I I I I I I I I I I I I I I I I I I I I I II II II I
Sbjct: 1940 CAAGATCGGCGATCGCGTTTCTGGa^^GGCCATATCACCTGTGGTCATTGCCGCAACTG 1999
Query: 336 TCGTGGTGGTCGTACCCATTTGTGCCGCAACACNATAGGCGTTGGTGTTAATCGCCCGGG 3 95
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 IIIIMIIIIIIIIIIMIIIMIII
Sbjct: 2000 TCGTGGTGGTCGTACCCATTTGTGCCGCAACACSATAGGCGTTGGTGTTAATCGCCCGGG 2059
Query: 3 96 CTGCTTTGCCGAATATCTGGTGATCCCGGCATTCAACGCCTTCAAAATCCCCGACAATAT 455
1 1 1 1 1 1 1 1 i I i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 J 1 1 i I
Sbjct: 2060 CTGCTTTGCCGAATATCTGGTGATCCCGGCATTCAACGCCTTCAAAATCCCCGACAATAT 2119
Query: 456 TTCCGATGACTTAGCCGCAATTTTTGATCCCTTCGGT7AACGCCGTGCATACC 507
I j I ! ' 1 1 1 1 1 1 1 1 1 i E 1 1 1 i 1 1 i 1 1 1 1 1 1 1 1 1 1 1 [ 1 1 1 f 1 1 1 1 1 1 1
Sbjct: 2120 TTCCGATGACTTAGCCGCAATTTTTGATCCCTTCGGTAACGCCGTGCATACC 2171
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Score = 418 (115.5 bits), Expect = 1.3e-215, Sum P(2) = 1.3e-215
Identities = 84/85 (98%), Positives = 84/85 (98%), Strand = Plus/Plus
Query: 507 CCGCGCTGTCGTTTGATCTGGTGGGCGAANATGTGCTGGTTTCTGGTGCAGGCCCGATTG 566
IIIIIIIMIIIMMIIIIIIMIIMI llllllllllllllllllllllllllllll
Sbjct: 2170 CCGCGCTGTCGTTTGATCTGGTGGGCGAAGATGTGCTGGTTTCTGGTGCAGGCCCGATTG 2229
Query: 567 GTATTATGGCAGCGGCGGTGGCGAA 591
IIIIMIIIIIIIMIIIIIMIM
Sbjct: 2230 GTATTATGGCAGCGGCGGTGGCGAA 2254
Figure 12. Sequence data from tdh 1939-2333 using primer 636
emb|X06690|ECKBLTDH E. coli genes tdh and kbl
Length = 3563
Plus Strand HSPs:
Score = 1948 (538.3 bits), Expect = 9.4e-203, SumP(3) = 9.4e-203
Identities = 392/395 (99%), Positives = 392/395 (99%), Strand = Plus / Plus
Query: 30 TCAAGATCGGCGATCGCGTTTCTGGCTGCGGCCATATCACCTGTGGTCATTGCCGCAACT 89
I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sbjct: 193 9 TCAAGATCGGCGATCGCGTTTCTGGCGftAGGCCATATCACCTGTGGTCATTGCCGCAACT 199
Query: 90 GTCGTGGTGGTCGTACCCATTTGTGCCGCAACACGATAGGCGTTGGTGTTAATCGCCCGG 149
I I I I I I I II I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I
Sbjct: 1999 GTCGTGGTGGTCGTACCCATTTGTGCCGCAACACGATAGGCGTTGGTGTTAATCGCCCGG 2056
Query: 150 GCTGCTTTGCCGAATATCTGGTGATCCCGGCATTCAACGCCTTCAAAATCCCCGACAATA 2 09
IIIIIIIMIIIIIIIIIIIIIIMIIIIIIIIMIIIMIIIIIIIIIIIMIIIIMI
Sbjct: 2059 GCTGCTTTGCCGAATATCTGGTGATCCCGGCATTCAACGCCTTCAAAATCCCCGACAATA 211E
Query: 210 TTTCCGATGACTTAGCCGCAATTTTTGATCCCTTCGGTAACGCCGTGCATACCGCGCTGT 269
M 1 1 II M II 1 1 M 1 1 1 1 1 1 1 1 i I M II II I II M 1 1 M M 1 1 1 M 1 1 1 1 M 1 1 1 M M I
Sbjct: 2119 TTTCCGATGACTTAGCCGCAATTTTTGATCCCTTCGGTAACGCCGTGCATACCGCGCTGT 2176
Query: 270 CGTTTGATCTGGTGGGCGAAgATGTGCTGGTTTCTGGTGCAGGCCCGATTGGTATTATGG 32 9
II Ml Ml Ml II II I III III III III II III II II I II I III MM II I II II I II II
Sbjct: 2179 CGTTTGATCTGGTGGGCGAASATGTGCTGGTTTCTGGTGCAGGCCCGATTGGTATTATGG 223 E
Query: 33 0 CAGCGGCGGTGGCGAAACACGTTGGTGCACGCAATGTGGTGATCACTGATGTTAACGAAT 389
II M 1 1 1 1 M 1 1 1 1 II M 1 1 1 II M 1 1 1 1 1 1 1 M I M I M 1 1 1 1 1 1 11 1 1 1 1 1 1 1 M II I
Sbjct: 223 9 CAGCGGCGGTGGCGAAACACGTTGGTGCACGCAATGTGGTGATCACTGATGTTAACGAAT 22 9E
Query: 3 90 ACCGCCTTGAGCTGGCGCGTAAAATGGGTATCACC 424
MMMMMMMMMMMMMIMMIMI
Sbjct: 2299 ACCGCCTTGAGCTGGCGCGTAAAATGGGTATCACC 2333
Figure 13. Sequence data from tdh 2066-2465 using primer 103
emb|X06690|ECKBLTDH E. coli genes tdh and kbl
Length = 3563
Minus Strand HSPs:
Score = 1993 (550.7 bits), Expect = 4.4e-158, P = 4.4e-158
Identities = 399/400 (99%), Positives = 399/400 (99%), Strand =Minus / Plus
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Query: 400 TGCCGAATATCTGGTGATCCCGGCATTCAACGCCTTCAAAATCCCCGACAATATTTCCGA 341
MMMMMMMMMMMMMMMMMMMMMMMMMMIMIMM
Sbjct: 2066 TGCCGAATATCTGGTGATCCCGGCATTCAACGCCTTCAAAATCCCCGACAATATTTCCGA 2125
Query: 340 TGACTTAGCCGCAATTTTTGATCCNTTCGGTAACGCCGTGCATACCGCGCTGTCGTTTGA 2 81
MMMMMMIMMMIMM I II I II I II I II II II I II I II II I M II M 1 1 M
Sbjct: 2126 TGACTTAGCCGCAATTTTTGATCCCTTCGGTAACGCCGTGCATACCGCGCTGTCGTTTGA 2185
Query: 280 TCTGGTGGGCGAAGATGTGCTGGTTTCTGGTGCAGGCCCGATTGGTATTATGGCAGCGGC 221
MMMMMMMMMMMMMMMMMMMMMMMMMMMIIMM
Sbjct: 2186 TCTGGTGGGCGAAGATGTGCTGGTTTCTGGTGCAGGCCCGATTGGTATTATGGCAGCGGC 2245
Query: 220 GGTGGCGAAACACGTTGGTGCACGCAATGTGGTGATCACTGATGTTAACGAATACCGCCT 161
MMMMMMMMMMMMMMMMMMMMMMMMMMMIIMM
Sbjct: 2246 GGTGGCGAAACACGTTGGTGCACGCAATGTGGTGATCACTGATGTTAACGAATACCGCCT 2305
Query: 160 TGAGCTGGCGCGTAAAATGGGTATCACCCGTGCGGTTAACGTCGCCAAAGAAAATCTCAA 101
MMMMMMMMMMMMMMMMMMMMMMMMMMMIIMM
Sbjct: 2306 TGAGCTGGCGCGTAAAATGGGTATCACCCGTGCGGTTAACGTCGCCAAAGAAAATCTCAA 2365
Query: 100 TGACGTGATGGCGGAGTTAGGCATGACCGAAGGTTTTGATGTCGGTCTGGAAATGTCCGG 41
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
Sbjct: 2366 TGACGTGATGGCGGAGTTAGGCATGACCGAAGGTTTTGATGTCGGTCTGGAAATGTCCGG 2425
Query: 40 TGCGCCGCCAGCGTTTCGTACCATGCTTGACACCATGAAT 1
MMMMMMMMMMMMMMIMMMIMM
Sbjct: 2426 TGCGCCGCCAGCGTTTCGTACCATGCTTGACACCATGAAT 2465
Figure 14. Sequence data from tdh 2439-2729 using primer 030
emb|X06690|ECKBLTDH E. coli genes tdh and kbl
Length = 3563
Minus Strand HSPs:
Score = 1610 (444.9 bits), Expect = 4.9e-175, Sum P(6) = 4.9e-175
Identities = 322/322 (100%), Positives = 322/322 (100%), Strand =Minus / Plus
Query: 400 TTTCGTACCATGCTTGACACCATGAATCACGGCGGCCGTATTGCGATGCTGGGTATTCCG 341
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
Sbjct: 243 9 TTTCGTACCATGCTTGACACCATGAATCACGGCGGCCGTATTGCGATGCTGGGTATTCCG 2498
Query: 340 CCGTCTGATATGTCTATCGACTGGACCAAAGTGATCTTTAAAGGCTTGTTCATTAAAGGT 281
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
Sbjct: 24 99 CCGTCTGATATGTCTATCGACTGGACCAAAGTGATCTTTAAAGGCTTGTTCATTAAAGGT 2558
Query: 280 ATTTACGGTCGTGAGATGTTTGAAACCTGGTACAAGATGGCGGCGCTGATTCAGTCTGGC 221
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
Sbjct: 2559 ATTTACGGTCGTGAGATGTTTGAAACCTGGTACAAGATGGCGGCGCTGATTCAGTCTGGC 2618
Query: 220 CTCGATCTTTCGCCGATCATTACCCATCGTTTCTCTATCGATGATTTCCAGAAGGGCTTT 161
Mill II II I MM IMMMMIMI II III III MUM II Mill MINI I II III
Sbjct: 2619 CTCGATCTTTCGCCGATCATTACCCATCGTTTCTCTATCGATGATTTCCAGAAGGGCTTT 26 78
Query: 160 GACGCTATGCGTTCGGGCCAGTCCGGGAAAGTTATTCTGAGCTGGGATTA&CACGAACAA 101
I II I I I II II II II I II II II II II II II II II I II II II II II II II I 111 I II I II I I




Sbjct: 2739 GGGCTGGTATTCCAGCCCTTTT 2760
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4. Purification of TDH E88C from extracts ofE.coli SP1192
Wild type threonine dehydrogenase was reproducibly obtained in homogeneous form
from extracts ofE.coli SBD76 cells using two chromatography steps-DEAE-Sephadex and Blue
Dextran-Sepharose
4B.52
The second step using blue Dextran-Sepharose 4B was especially
effective since the dye (Cibacron Blue F3GA, Fig. 15) was thought to bind specifically to the
NAD+-binding site on the threonine dehydrogenase. All the other proteins in the DEAE ion-
exchange pool were washed through the column, leaving only the TDH bound. The bound TDH
was then released with an
NAD+
wash.
Attempts were made to purify TDH E88C by exactly the same procedure. However, for
the mutated TDH, there was always one other protein band that coeluted with the TDH when the
blue column was washed with buffer containing NAD+. This was still a crucial step during
purification, since it removed most of the other proteins present after the ion exchange step.
Therefore, a modified procedure was developed. The crude extracts containing TDH E88C was
applied to TOYOPEAL HW-55S gel filtration column (elution profile for TDH activity is
shown on Figure 16). Active fractions were pooled and applied to a Cibacron Blue F3GA dye-
ligand affinity column (elution profile for TDH activity is shown on Figure 17), The active
fraction pools were concentrated and finally applied to a HQ ion-exchange column (elution
profile for TDH activity is shown on Figure 18).
SDS-PAGE gel electrophoresis showed a single band after the HQ ion-exchange column,
which demonstrated that TDH E88C was obtained in homogenous form after three
chromatography steps (Figure 19). Based on the molecular weight standard curve (log MW vs.
Rm, see Figure 20), the subunit molecular weight of purified TDH band is about 38,800, so the
estimated molecular weight of TDH in its tetrameric form is 155,000, while the literature value is
40
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148,000 . The protein determination and TDH activity assay are summarized in table HI. As
seen from table IV, most of the protein was lost during reactive blue affinity column ( protein
yield goes from 74% down t ol7%), which is consistent with the elution profile (Fig. 17) of the
affinity column for mutant TDH that the spectrum has a very wide peak. Specific activity of pure
TDH E88C mutant is only 0.177 U/mg, which is decreased dramatically compared to the wild
type TDH.
Ri = S02ONa or H
R2 = H or S02ONa









Figure 16. Elution profile for TDH activity for the gel filtration column. Injection volume: 5 mL crude
extract. Flow rate: 2 mL/min. Buffer: 20 mM Tris, pH 8.5 with 100 mM KC1. Detector wavelength at 290






Figure 17. Elution profile for TDH activity for blue dye affinity column. Injection volume: 1 mL. Flow
rate: 2 mL/min. Loading buffer: 20 mM Tris, pH 7.5 with 100 mM KC1. Elution buffer: 20 mM Tris pH
8.5 with 100 mM KC1 and 5 mM NAD. Detector wavelength at 280 nm, AUFS=2.0. Fraction collector: 1
min/tube. TDH activity was detected at fraction 17 and 18.
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Figure 18. Elution profile for TDH activity from HQ ion-exchange column. Injection volume: 1 mL.
Flow rate: 4 mL/min. Buffer: 20 mM Tris pH 8.5 with KCI gradient. Detector wavelength at 280 nm,
AUFS=2.0. Fraction collector: 0.5 min/tube. TDH activity was detected at fraction 42 when salt










Figure 19. SDS-PAGE Gel Electrophoresis showing samples after each purification
step. Lane 1: MW standard; lane 2:crude extract; lane 3: gel filtration; lane 4: blue
F3GA; lane 5: HQ ion-exchange.































































































































































































































































*t* Challenges in generating the mutant enzyme and in purifying the enzyme
The first challenge encountered in our research was to create the mutated plasmid TDH
E88C using PCR. We started with a protocol taken from Molecular Biology: Current
Innovations and Future
Trends?0
AmpliTaq Gold Taq Polymerase, a chemically modified form
of AmpliTaq DNA polymerase from Perkin-Elmer Co. was used to increase the specificity, and
71
sensitivity of PCR product. The polymerase adjunct, Taq Extender PCR additive was added to
increase reliability of long
sequences.72
Dpnl endonuclease (target sequence:
5'-Gm
ATC-37) was
used to digest parental DNA and select for mutation-containing amplified DNA. Pfu DNA
polymerase was used to remove any extra bases at the
3'
ends of the product added by Taq
polymerase. Then the linear PCR product was ligated by T4 DNA ligase. The protocol seems to
have incorporated many techniques, but no band was ever shown on the DNA agarose gel. One
possible explanation is that the AmpliTaq Gold Taq Polymerase did not work for us since a few
other students tried it without success.
We then moved to the QuikChange Site -DirectedMutagenesis Kit from Stratagene. This
kit uses pfu DNA polymerase, omitting Taq polymerase entirely. After trying different template
concentrations: 5 ng, 10 ng, 20 ng and 50 ng, the right PCR conditions were finally found (DNA
template concentration at 10 ng) as described in p. 23 and the mutant was obtained. PCR is a
very simple, widely used reliable technique,
but establishing a good condition for each individual
experiment can be time-consuming and tricky. Good lab practice is especially important when
dealing with the microquantities employed in PCR.
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Another challenge was to purify the mutant TDH. Our first attempt was to follow the
method that reproducibly yielded obtained homogeneous wild type TDH from extracts of E.coli




However, for the mutant TDH, there was always one other protein band that
coeluted with the TDH. Therefore, a modified three-step chromotographic procedure was
developed. The crude extracts containing TDH E88C was applied to TOYOPEAL HW-55S gel
filtration column, active fractions were pooled and applied to a Cibacron Blue F3GA dye-ligand
affinity column, then the active fraction pools were concentrated and finally applied to a HQ
ion-
exchange column. SDS-PAGE gel electrophoresis showed that TDH E88C was finally obtained
in homogenous form.
? Mutations to glutamate or aspartate residues in ADH
Table TV listed some of the mutations that have been done on alcohol dehydrogenases.
Below is a more detailed description on two studies that reveal the function of carboxylate
groups near the active zinc site.
A Glu residue in the sorbital dehydrogenase has been postulated to replace the cysteine of
alcohol dehydrogenase as a ligand to the active-site zinc atom based on modeling the primary
structure of sheep liver
SDH13
to the three-dimensional structure of horse Ever alcohol
dehydrogenate and extended X-ray absorption fine-structure
studies.73
Site-directed mutagenesis
was carried out on rat
SDH74
to replace Glu155 with a Cys to mimic the alcohol dehydrogenase
relationships, and an Ala. Glul55Ala creates an inactive enzyme, showing that proper active-site
interaction is lost. Cys substitution is active, but the catalytic efficiency decreases markedly. The




Another study was done on yeast alcohol dehydrogenase to replace Glu68 to glutamine
and Asp49 to Asparagine (residue numbering as for horse Ever enzyme). The results show that
removing the negative charges near the active site zinc considerably decreases catalysis. Gin
substitution at position 68 reduced the catalytic efficiency by 100-fold for both efhanol oxidation
and acetaldehyde reduction; Asn substitution at position 49 decreased efficiencies 1000-fold.
Turnover numbers with efhanol decreased by about 40-fold and affinities for coenzymes,
substrates, and inhibitors decreased by up to 20-fold.
Although the carboxyl groups of Asp49 and Glu68 of yeast alcohol dehydrogenase are
not direct ligands to the active site zinc based on the structures of
HLADH,77
they appear
necessary to modulate the effective charge on the zinc ion and create an favorable electrostatic
environment for rearrangements around the catalytic zinc. The mutations may slightly alter the
secondary structure near the active site zinc by the removal of negative charges and result in poor
binding of the coenzymes and substrates with the enzyme. Secondly, the increased polarizing
electrostatic potential near the active site zinc, due to removal of negative charges, decreases the
pKa value of the alcohol bound to zinc. This causes slower hydride transfer which decreases the
activity of mutants for oxidizing ethanol. Therefore, two basic effects-structural perturbations




Table IV List of site directed mutagenesis in alcohol dehydrogenase












All the mutants result in enzymes with
lower affinity for coenzyme than
wild-
type fcfc.





The Vmax/Km value of mutant for
secondary alcohol and stereoselectivity
for enantiomeric alcohol are similar to
that of aoc but the dependency of
Vmax/Km on primary alcohol chain
length is similar to PiPl5 not aoc.
Position 93 and 94 account for
substrate specificity between
isoenzyme PiPi and aa to some
extends.
The T48S mutant is inhibited by
testosterone and has steroid
dehydrogenase activity as yy.
Meanwhile several kinetic constants are
affected in the direction toward those
characteristics of the yy isozyme too.
Alanine at position 48 creates an
inactive enzyme.
Position 48 is necessary to obtain






The catalytic efficiencies for ethanol
oxidation and acetaldehyde reduction




Position 49 and 68 are in the second





The Km (nadph) of the mutant is much
higher than the Km for WT enzyme,
while the WKm ratio with NADPH
was decreased 25 fold.






El55A has no activity. E155C is partly
active, but very unstable.








Mutations at these two residues
dramatically increase the Km values
toward small alcohol substrates, but the
Km values for substrates with five or
more carbons are less affected.
Substrate binding pocket. The
interactions between the enzyme and
smaller substrates are affected while
the binding of longer alcohol is not.
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The activities of the mutant enzymes
toward ethanol are essentially identical
to the native enzyme, but mutagenesis
greatly decrease the k^/Km for
glutathione-dependent formaldehyde
oxidation and their activation by fatty
acids are markedly attenuated.
Substrate binding pocket for
glutathione-dependent formaldehyde
dehydrogenase activity.
All mutations result in inactive,
unstable enzymes. Northern-blot
analysis revealed the presence of the
expected mRNAs from expression
plasmids constructed with the different
mutated and non-mutated ADH, and
Westem-blot analysis give faint signals
for the mutated recombinant proteins
from crude extracts.
Cys97, 100, 103 and 111 are the
ligands to the structural zinc and the
structural role of the zinc atommay
involve conservation of interfaces
regulating the enzyme quaternary
structure.
N57L, Y93F and the double mutant all
cause considerable loss of the
formaldehyde dehydrogenase activity.
At the same time, the alcohol
dehydrogenase activity of the double
mutant has gained a characteristic class
I property.
Position57 and 93 are important for
class differentiation. Exchange at
these positions from class IH wild-
type to class I wild-type residues,


















G14V is virtually inactive, and G14A
causes a 31% decrease in activity.
Thermal denaturation and kinetic and
inhibition further demonstrate that
replacing
glycine-14 with either alanine
or valine leads to structural changes in
the NAD binding domain. All the
cysteine mutants cause no decreases in
the catalytic activity of the enzyme.
Glyl4 plays a crucial role in
maintaining the correct conformation
in the NAD binding domain.
Neither of the cysteine residues is
essential for catalysis.
Y152F, Y152Q, Y152H and K156I are
catalytically inactive. The activities of
Y152C and K156R toward ethanol are
greatly decreased, but the Km (nad) is
essentially unaltered. Furthermore,
these two mutant have different
substrate specificity and behave
differently on competitive inhibition
than wild-type ADH.
Tyr-152 and Lys-156 have essential
roles in the interaction of the
substrate with the enzyme, but not in
the binding of the cofactor to the
enzyme.
Mutations at position 19, 38 and 214
affect the Km for NAD without altering
the Km for alcohol. Unlike the wild
type, G19A shows no activity when the
cofactorNADP is used.
Asp38 and Pro214 interact with the
cofactor NAD. Glyl9 plays a role in
the recognition of cofactor NADP
and NAD.
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? Mutations in E.coli TDH
Random mutagenesis with hydroxylamine was done on TDH from E.coli by
Yen-Wen
Chen.88
The mutants were divided into 4 groups:
(1) Amino acid changes that are possible ligands to Zn +. Mutant Cys38Tyr shows no
TDH activity, which confirms Cys38 is a ligand to the active site zinc. Prol49Ser and
Gly62Asp mutants are next to two other possible Zn-ligands (His-63 and
Asp-148)
and show significant effect on TDH activity.
(2) Mutations on a few conserved glycine residues. Glycine residue is important in
protein folding because its short side chain can fit unusual conformational changes.
Gly62Asp, Gly263Asp and Gly285Asp all result in inactive enzymes. The
substitution ofAsp for gly disrupts the secondary structure and protein folding.
(3) Substitutions at the substrate or coenzyme binding site. Mutations Gly89Asp,
Alal72Val, Glyl71Asp and Glu238Lys belong to this group. Based on homology to
the 3-D structure of LADH, Gly-89 is one of the residues that form the substrate-
binding pocket. The other three residues are in the
NAD+
binding site.
(4) Mutations for further research. The results of some of the mutations such as
Arg97Cys, Arg97His, Glyll4Ser, Glyll9Ser,Gly263Asp and Glu88Lys can't be
explained by the current knowledge, which demands further study.
Site-directed mutagenesis of His90 and Cys38 of E.coli TDH was done by Adam R.
Johnson.28
His90 was changed to Arg, Asp and Ala. All three mutants show decreased TDH
activity and altered substrate specificity
which suggest that His-90 plays a role in the formation
substrate binding pocket. Another mutation was Cys38Glu. The mutant retains only about 1% of
50
the level of enzymatic activity ofWT TDH. Therefore, it supports the idea that Cys38 is a ligand
to the active site zinc.
Our experiments found that the specific activity of pure TDH E88C mutant was 0.177
U/mg, the total activity for the crude extract is 1.67 U. Pure TDH of E.coli K-12, designated
SBD76 shows specific activity of 34 U/mg, while the total activity for the crude extract is 2463
on
U. One unit of enzyme activity is the amount that catalyzed the formation of 1.0 (imol of
NADH/min. It is obvious that the total activity and specificity activity of the TDH E88C mutant
is significantly decreased compared to the wild type TDH. The loss of the activity of the mutant
might be due to many factors such as material loss or the loss of catalytic zinc during three-step
chromatography purification. Glu-88 may be involved in electrostatic stabilization of the active
site Zn +, as was seem in Yeast ADH I. No data on steady state kinetics value has been
obtained thus far, making it impossible to give a comprehensive explanation of the role of the
E88C playing in the enzymatic catalysis.
Further studies should be done in order to fully understand the function of glutamate 88:
Construction of another mutant, Glu88Ala, using site-directed mutagenesis to see if this is an
essential residue.
Comparison of chromatographic behavior of three enzyme forms.
Determination of the zinc content of both the wild-type and mutant forms of TDH E88C and
E88A using atomic absorption spectrophotometric analyses.
Circular dichroism spectra of WT TDH, TDH E88C and E88A to detect the secondary
structure of each protein.
Chemical characterization of TDH wild type, TDH E88C and TDH E88A: stability to heat,
effect of pH on the activity, assay for total SH groups on each enzyme form, peptide mapping
51
by HPLC or Capillary Eletrophoresis to see if the mutations change the digestion patterns,
etc.
Steady state enzyme kinetics of TDH E88C, TDH E88A, and TDHWT.
In summary, the mutant TDH E88C has been generated using PCR methods, the
sequence of the mutant gene has been confirmed, and the protein has been purified to
homogeneity. TDH E88C displays greatly deceased total activity and specific activity compared
to TDH WT. Further experiments are necessary to clearly define the role of Glu-88 in the
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